Mark Lampert to Risk Assessment
This is a "connection" page, showing publications Mark Lampert has written about Risk Assessment.
Connection Strength
0.015
-
Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol. 2012 Apr 03; 59(14):1312-9.
Score: 0.015